Patent · US Active

Treating sexual desire disorders with flibanserin

US8227471B2 · kind B2 · utility

10Cited by
44References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 21, 2006
Grant dateJul 24, 2012
Priority date
Expiry dateSep 27, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.